Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Endocrine 5Gastrointestinal 2Tumor-Agnostic 1Dermatologic 1

Conditions

Skin Neoplasms 1Rosacea 1Psoriasis 1Melanoma 1Dermatitis, Atopic 1

Interventions

Nivolumab 168Ipilimumab 152pembrolizumab 143Cyclophosphamide 126Interleukin-2 70aldesleukin 69fludarabine phosphate 68Radiotherapy 67Biopsy 53Temozolomide 48Blood Specimen Collection 45Peripheral Blood Stem Cell Transplantation 44fludarabine 43Radiosurgery 40trametinib 38Vemurafenib 36dabrafenib 33sargramostim 32Bevacizumab 31Aminolevulinic Acid 31Magnetic Resonance Spectroscopy 30Mycophenolic Acid 29Specimen Handling 28Whole-Body Irradiation 27Photochemotherapy 26Imiquimod 26CTLA-4 Antigen 26Busulfan 26Tacrolimus 25Surveys and Questionnaires 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Eating × Dermatologic × Clear all
NCT03253666 2020-07-15

Nurses' Health Study and Health Professionals Follow-Up Study (Dermatological Component)

Harvard School of Public Health (HSPH)

Completed
173,229 enrolled
Dermatologic

Dermatitis, Atopic, Melanoma, Psoriasis, Rosacea, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡